Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation
This study found no significant difference in CIHL between different DIVHS during cisplatin-based chemoradiation in HNSCC patients.
Authors
- Alex E. Hoetink (ORCID: https://orcid.org/0000-0002-7417-5546)
- Anouk W. M. A. Schaeffers (ORCID: https://orcid.org/0000-0002-7952-8734)
- Mirjam Crul (ORCID: https://orcid.org/0000-0002-4929-2388)
- M. KOOT
- Mark De Ridder (ORCID: https://orcid.org/0000-0003-4433-8807)
- Tim Schutte (ORCID: https://orcid.org/0000-0002-4096-0917)
- Charlotte L. Zuur (ORCID: https://orcid.org/0000-0002-1777-012X)
- Dorieke E M van Balen
- Lot A. Devriese (ORCID: https://orcid.org/0009-0009-9324-7814)
- Anouk V. M. Burger (ORCID: https://orcid.org/0000-0003-0435-3981)
Institutions
- Utrecht University (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Oncode Institute (NL)
Publication Details
- Journal
- Oral Oncology
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1016/j.oraloncology.2025.107246
- Citations
- 3
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56